AUTHOR=Lotz-Havla Amelie S. , Weiß Katharina , Schiergens Katharina , Regenauer-Vandewiele Stephanie , Parhofer Klaus G. , Christmann Tara , Böhm Luise , Havla Joachim , Maier Esther M. TITLE=Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency JOURNAL=Frontiers in Neurology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.780624 DOI=10.3389/fneur.2021.780624 ISSN=1664-2295 ABSTRACT=
In phenylalanine hydroxylase (PAH) deficiency, an easily feasible method to access the progression of neurodegeneration is warranted to contribute to current discussions on treatment indications and targets. The objective of the present study was to investigate whether optical coherence tomography (OCT) measures as markers of neurodegeneration differ between patients with PAH deficiency and healthy controls (HCs) according to phenotype and metabolic control. In this single-center cross-sectional study, 92 patients with different phenotypes of PAH deficiency [PAH deficiency not requiring treatment, early treated phenylketonuria (ETPKU), and late-diagnosed phenylketonuria (PKU)] compared with 76 HCs were examined using spectral-domain OCT. Indices of phenylalanine elevation and variability were correlated with OCT parameters. Late-diagnosed PKU patients showed reduced peripapillary retinal nerve fiber layer (pRNFL) thickness and combined ganglion cell and inner plexiform layer (GCIPL) volume. Adult ETPKU patients were found to have lower GCIPL volume (